1. Roth GA, Johnson C, Abajobir A, Abd-Allah F, Abera SF, Abyu G, et al. Global, regional, and national burden of cardiovascular diseases for 10 causes, 1990 to 2015. J Am Coll Cardiol. 2017; 70(1):1-25. doi:10.1016/j.jacc.2017.04.052 PMid:28527533 PMCid:PMC5491406

2. Ding SJ, Ding H, Kan MF, Zhuang Y, Xia DY, Sheng SM, et al. AComputer-AidedHeart Valve Disease Diagnosis SystemBasedon Machine Learning. J Healthc Eng. 2023; 73:1-16. doi:10.1155/2023/7382316 PMid:36726774 PMCid:PMC9886464

3. Aluru JS, Barsouk A, Kalyan Saginala K, Rawla P, Barsouk A. Valvular Heart Disease Epidemiology. Med. Sci. 2022; 22(3):10-32. doi:10.3390/medsci10020032 PMid:35736352 PMCid:PMC9228968

4. Roth GA, Mensah GA, Fuster V. The Global Burden of Cardiovascular Diseases and Risks: A Compass for Global Action. J Am Coll Cardiol. 2020; 76(25): 2980-9. doi:10.1016/j.jacc.2020.11.021 PMid:33309174

5. Mensah GA, Roth GA, Fuster V. The Global Burden of Cardiovascular Diseases and Risk Factors. 2020 and Beyond. J Am Coll Cardiol. 2019; 74(20): 2529-32. doi:10.1016/j.jacc.2019.10.009 PMid:31727292

6. Ronco D, Buttiglione G, Andrea Garatti A, Parolari A. Biology of mitral valve prolapse: from general mechanisms to advanced molecular patterns-a narrative review. Front Cardiovasc Med. 2023; 7(84): 1-13. doi:10.3389/fcvm.2023.1128195 PMid:37332582 PMCid:PMC10272793

7. Narula N, Nupoor Narula A, Argulian E. The Thickened Valve. JACC Case Rep. 2020; 2(12): 1845-8. doi:10.1016/j.jaccas.2020.09.010 PMid:34317064 PMCid:PMC8299234

8. Griffith E, Nunlist E. Mitral valve prolapse in adolescent female with hyperthyroidism. Prog Pediatr Cardiol. 2020; 58: 101264. doi:10.1016/j.ppedcard.2020.101264 PMid:32837146 PMCid:PMC7315958

9. Althunayyan A, Petersen SE, Lloyd G, Bhattacharyya S. Mitral valve prolapse. Expert Rev Cardiovasc Ther. 2019; 17(1): 43-51. doi:10.1080/14779072.2019.1553619 PMid:30484338

10. Pistelli L, Vetta G, Parlavecchio A, Crea P, Parisi F, Magnocavallo M, et al. Arrhythmic risk profile in mitral valve prolapse: A systematic review and metanalysis of 1715 patients. J Cardiovasc Electrophysiol. 2024; 35(2): 290-300. doi:10.1111/jce.16149 PMid:38098308

11. Delwarde C, Capoulade R, Mérot J, Le Scouarnec S, Bouatia-Naji N, Yu M, et al. Genetics and pathophysiology of mitral valve prolapse. Cardiovasc Med. 2023; 10(3): 1 -14. doi:10.3389/fcvm.2023.1077788 PMid:36873395 PMCid:PMC9978496

12. Cat AN, Touyz RM. A new look at the renin-angiotensin system-Focusing on the vascular system. Peptides. 2011; 32 (10): 2141-50. doi:10.1016/j.peptides.2011.09.010 PMid:21945916

13. Wu CH, Moradi SM, Chen JZ, Sawada H, Daugherty A, Lu HS. Renin-Angiotensin System and Cardiovascular Functions. Arterioscler Thromb Vasc Biol. 2018; 38(7): 108-16. doi:10.1161/ATVBAHA.118.311282 PMCid:PMC6039412

14. Vladeanu MC, Bojan IB, Bojan A, Iliescu D, Badescu MC, Badulescu OV, et al. Angiotensin-converting enzyme gene D-allele and the severity of coronary artery disease. Exp Ther Med. 2020; 20(4): 3407-11. doi:10.3892/etm.2020.8978 PMiD: 32905120 PMCiD: PMC7465281

15. Gibb AA, Lazaropoulos MP, Elrod JW. Myofibroblasts and fibrosis: mitochondrial and metabolic control of cellular differentiation. Circ Res. 2020; 17(3): 427-47. doi:10.1161/CIRCRESAHA.120.316958 PMid:32673537 PMCid:PMC7982967

16. Liu M, Yi J, Tang W. Association between angiotensin converting enzyme gene polymorphism and essential hypertension: A systematic review and meta-analysis. J Renin Angiotensin Aldosterone Syst. 2021:22(1): 1-12. doi:10.1177/1470320321995074 PMid:33726555 PMCid:PMC7983243

17. Abchee A, El-Sibai M, Youhanna S, Yeretzian JS, Estephan H, Makhoul NJ, et al. Abchee A, El-Sibai M, Youhanna S, et al. The I allele of the angiotensin converting enzyme I/D polymorphism confers protection against coronary artery disease. Coron Artery Dis. 2010; 21(3): 151-6. doi:10.1097/MCA.0b013e328335a042 PMid:20299978

18. Mustafa AI, Ibrahim SE, Gohary YM, Al-Husseini NF, Fawzy E, El-Shimi OS. Association between angiotensin-converting enzyme gene insertion deletion polymorphism and androgenetic alopecia susceptibility among Egyptian patients: a preliminary case-controlled study. J Cosmet Dermatol. 2022; 21(6):2629-34. doi:10.1111/jocd.14434 PMid:34499796

19. Bartakova J, Deissova T, Slezakova S, Bartova J, Petanova J, Kuklinek P, et al. Association of the angiotensin I converting enzyme (ACE) gene polymorphisms with recurrent aphthous stomatitis in the Czech population: case-control study. BMC Oral Health. 2022; 22(1):1-9. doi:10.1186/s12903-022-02115-3 PMid:35305614 PMCid:PMC8933959

20. Jay Ramchand J, Burrell LM. Circulating ACE: a novel biomarker of cardiovascular risk. Lancet. 2020; 396(10256): 937-9. doi:10.1016/S0140-6736(20)32011-0 PMid:33010824

21. Momeni-Moghaddam MA, Chahkandi H, Amini Beidokhti NA, RahmaniM,Salarbashi D, Khorasani M. Angiotensin converting enzyme I/D gene polymorphism and type 2 diabetes risk in Iranian people. Nucleosides Nucleotides Nucleic Acids. 2024:1-10. doi:10.1080/15257770.2024.2343904 PMid:38651253

22. Guicciardi NA, De Bonis M, Di Resta C, Ascione G, Alfieri O, Maisano F, et al. Genetic background of mitral valve prolapse. Rev. Cardiovasc Med. 2022; 23(3): 17-25. doi:10.31083/j.rcm2303096 PMid:35345263

23. Le Tourneau T, Mérot J, Rimbert A, Le Scouarnec S, Probst V, Le Marec H, et al. Genetics of syndromic and non-syndromic mitral valve prolapse. Heart J. 2018: 104(12): 978-84. doi:10.1136/heartjnl-2017-312420 PMid:29352010 PMCid:PMC6168077

24. O'Brien KD, Shavelle DM, Caulfield MT, McDonald TO, Olin-Lewis K, Otto CM, et al. Association of angiotensin- converting enzyme with low-density lipoprotein in aortic valvular lesions and in human plasma. Circulation. 2002; 106(17):2224-30. doi:10.1161/01.CIR.0000035655.45453.D2 PMid:12390952

25. Yuanyuan Lv, Wenying Zhao, Laikang Yu, Ji-Guo Yu, Li Zhao. Angiotensin-Converting Enzyme Gene D/I Polymorphism in Relation to Endothelial Function and Endothelial-Released Factors in Chinese Women. Front Physiol. 2020; 11(951): 1-11. doi:10.3389/fphys.2020.00951 PMid:33041838 PMCid:PMC7526498

26. Tran DC, Gia Le LH, Thai TT, Hoang SV, Do MD, Truong BQ. Association between ACE I/D genetic polymorphism and the severity of coronary artery disease in Vietnamese patients with acute myocardial infarction. Front Cardiovasc Med. 2023; 3(10):1091612. doi:10.3389/fcvm.2023.1091612 PMid:37206099 PMCid:PMC10188916

27. Melake A, Nega Brhanie N. Association between ACE I/D Gene Polymorphism and Dyslipidemia in Hypertensive Patients with Ischemic Heart Disease Complication among Ethiopian Population. Front Neurol. 2023; 14:1-8. doi:10.2147/RRCC.S395780 PMiD: 37034069 PMCiD: PMC10073506

28. Vladeanu MC, Bojan IB, Bojan A, Iliescu D, Badescu MC, Badulescu OV, et al. Angiotensin-converting enzyme gene D-allele and the severity of coronary artery disease. Exp Ther Med. 2020; 20(4): 3407-1. doi:10.3892/etm.2020.8978 PMiD: 32905120 PMCiD: PMC7465281

29. Chou HT, PhD, Chen YT, Shi YR, Tsai FJ. Association between angiotensin I-converting enzyme gene insertion/deletion polymorphism and mitral valve prolapse syndrome. Am Heart J. 2003; 145(1): 169-73. doi:10.1067/mhj.2003.26 PMid:12514670

30. Fatini C, Attanasio M, Porciani C, Sticchi E, Padeletti L, Lapini I, et al. AGT and ACE genes influence classic mitral valve prolapse predisposition in Marfan patients. Int J Cardiol. 2008; 123(3): 293-7. doi:10.1016/j.ijcard.2006.12.015 PMid:17379330

31. Rehman S, Saba N, Naveed Akhtar N, Munir S, Ahmed W, Khanum A. Angiotensin Converting Enzyme Gene I/D Polymorphism in Pakistani Rheumatic Heart Disease Patients and Healthy Controls. Int Cardiovasc Res J. 2015; 9(3): 169-72. doi:10.238/icrj.2015.25405 PMiD: 11238

32. Kumari N, Yadav A, Ahirwar R, Kumar Sagar S, P Mondal PR. Angiotensin converting enzyme (ACE) insertion/deletion (I/D) polymorphism and its association with cardiovascular adversities- A systematic review. Human Gene. 2022; 34:201117. doi:1016/j.humgen.2022.201117

33. Zhu YX, Liu G. The relationship between the insertion/deletion gene polymorphism of ACE and atrial fibrillation in Chinese population: a meta-analysis. Food Sci Technol. 2020; 42(3): 1-6. doi:10.1590/fst.36020.

34. Ghaffarzadeh A, Nemati M, Hassan-Nejhad M, Khadem-Vatani K, Baghal-Sadriforoush S, Bagheri M. Association of angiotensin-converting enzyme gene variations with coronary artery disease in the Iranian population. ARYA Atheroscler. 2023; 19(1): 12-16.doi:org/10.48305/arya.2022.11869.2692 PMiD: 26240

35. Poorzand H, Fazeli B, Khajavi O, Gholoobi A, Keihanian F, Morovatdar N. Association of polymorphisms of renin angiotensin system and endothelial nitric Oxide synthase genes with premature cardiovascular disease in an Iranian population. BMC Cardiovascular Disord. 2023; 23(254): 1-6. doi:10.1186/s12872-023-03276-x PMid:37193968 PMCid:PMC10189996

36. Bahramali E, Rajabi M, Jamshidi J, Mohammad Mousavi S, Zarghami M, Manafi AR, Association of ACE gene D polymorphism with left ventricular hypertrophy in patients with diastolic heart failure: a case-control study. BMJ open 2016; 6(2): 1-6. doi:10.1136/bmjopen-2015-010282 PMid:26861937 PMCid:PMC4762084

37. Liu M, Yi J, Tang W. Association between angiotensin-converting enzyme gene polymorphism and essential hypertension: a systematic review and meta-analysis. J Renin Angiotensin Aldosterone Syst. 2021; 22(1): 1470320321995074. doi:10.1177/1470320321995074 PMid:33726555 PMCid:PMC7983243

38. El-Sayed Marei Y, Abdallah Bayoumy A, Mohamed Abulazm Nassar H, Mansour B, Bakeir Hamady A. The Relation betweenACEGene Polymorphism and the Severity of COVID-19 Infection. Int J Microbiol. 2023; 45:1-7. doi:10.1155/2023/4540287 PMid:36644496 PMCid:PMC9833908

39. Du J, Lan J, Yang H, Ying Q, Huang G, Mou J, et al. Association of angiotensin-converting enzyme insertion/deletion (ACE I/D) gene polymorphism with susceptibility to prostate cancer: an updated meta-analysis. World J Surg Oncol. 2022; 20(354):1-9. doi:10.1186/s12957-022-02812-x PMid:36329458 PMCid:PMC9635097